Journal
IMMUNOGENETICS
Volume 61, Issue 8, Pages 551-556Publisher
SPRINGER
DOI: 10.1007/s00251-009-0389-4
Keywords
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL); Single-nucleotide polymorphism (SNP); Fatty liver disease (FLD)
Categories
Funding
- National Natural Science Foundation of China [30872298]
Ask authors/readers for more resources
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfamily, and has been identified as a novel mediator of fatty liver disease (FLD). The aim of our study was to further investigate the relationship between TRAIL and FLD. We found that soluble TRAIL (sTRAIL) concentrations in non-alcoholic FLD (NAFLD) patients were significantly higher than those of controls, and that sTRAIL levels positively correlated with triglyceride concentrations in NAFLD patients. Our results also indicated that the AA/TT genotypes of TRAIL at 1525/1595 engendered a lower risk of FLD attack and a less severe form of steatosis for NAFLD patients in Chinese population. This study provides a means to test for susceptibility to FLD and may assist in the diagnosis of FLD. In addition, we found that 1525G/A and 1595C/T sites were in complete linkage disequilibrium in Chinese population. This might indicate a haplotype with high genetic frequency of TRAIL.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available